Insulin infographics
Boost cell-based vaccine production with Recombinant Insulin
Discover how to boost influenza virus and VLP production
Explore our infographic below to learn how Recombinant Insulin can significantly enhance cell-based vaccine production, including a 1.7-fold boost in influenza virus production and a 1.2-fold increase in VLP production. You can download the infographic in PDF format using the link at the bottom.
For more insights, explore the following case studies:
- Improving Influenza virus production in HEK293 cell culture supplemented with animal-free insulin. This study highlights how insulin alleviates growth limitations in chemically-defined media, enhances cell survival, and activates the PI3K/Akt pathway, resulting in a significant boost in influenza virus production using HEK293SF-3F6 cells.
- Supplementation of Recombinant Insulin to insect SF9 cell culture to improve cell growth and baculovirus-driven VLP production. This study demonstrates how recombinant insulin increases viable cell density and enhances baculovirus-driven VLP production by up to 1.2-fold in Sf9 cells grown in chemically-defined media, showcasing the potential for improving vaccine production systems.
